Primer on Cancer Immunotherapy and Radiation

When:  Sep 12, 2019 from 8:40 AM to 12:30 PM (ET)
The Primer session is jointly provided by the Society for Immunotherapy of Cancer (SITC) and the Postgraduate Institute for Medicine (PIM), in collaboration with Weill Cornell Medicine and Gustave Roussy.

The Primer Session on Cancer Immunotherapy and Radiation will be held on September 12, 2019 and is part of the 4th International Conference on Immunotherapy Radiotherapy Combinations from September 12 - 14, 2019. This session is CME-accredited.

Session Organizers:
Sandra Demaria, MD* – Weill Cornell Medicine
Karsten Pilones, MD, PhD* Weill Cornell Medicine

8:40 – 9:10 a.m.


Innate Immunity
Niroshana Anandasabapathy, MD, PhD* – Weill Cornell Medical College

9:10 – 9:40 a.m.

Adaptive Immunity
Gary Koretzky, MD – Weill Cornell Medical College

9:40 – 10:30 a.m.




Checkpoint blockade immunotherapy: Understanding activity, toxicity management and investigating mechanisms
Jedd D. Wolchok, MD* – Memorial Sloan Kettering Cancer Center

10:30 – 10:45 a.m.

Break

10:45 – 11:15 a.m.

Radiation Biology for Immunologists
William McBride, PhD – University of California, Los Angeles

11:15 – 11:45 a.m.


Mechanisms of response and resistance to radiation and immunotherapy
David Kirsch, MD, PhD – Duke University

11:45 a.m. – 12:15 p.m.

Radiation Effects on Tumor Microenvironment
Mary-Helen Barcellos-Hoff, PhD – University of California, San Francisco


*Denotes SITC Member

For more information, or to register, please click here.

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Society for Immunotherapy of Cancer.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME).

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


View the SITC Meeting Code of Conduct.

#ClinicalTrials
#CME
#CME
#CNE
#CPE
#Biomarkers
#InPersonEvent
#Collaboration
#SITC
#CombinationTherapy
#2019